Atlantic Health Strategies

Texas AI Law Takes Effect Limiting Behavioral Manipulation

Table of Contents

Ready to See Results?

From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.

A New Phase of State-Level AI Regulation Begins in Texas

As of January 1, 2026, Texas has joined a small but growing group of states implementing comprehensive artificial intelligence governance frameworks. The Texas Responsible Artificial Intelligence Governance Act, widely referred to as TRAIGA, officially moved from statute to enforcement, positioning Texas as one of the most consequential AI regulatory actors in the United States.¹

Unlike narrower state efforts that focus exclusively on healthcare, children, or biometric data, TRAIGA is intentionally expansive. It applies to private companies, technology vendors, and government agencies alike, and it asserts jurisdiction over any organization that develops, deploys, or offers AI systems used by Texas residents.² For healthcare leaders and behavioral health operators in particular, the law introduces a new compliance reality that intersects directly with clinical risk, digital therapeutics, and AI-enabled engagement tools.

Atlantic Health Strategies views TRAIGA not as an isolated legislative event, but as a signal. State attorneys general are increasingly willing to regulate AI through broad consumer protection and civil rights frameworks, even in the absence of federal consensus. Texas’s approach emphasizes enforcement authority, monetary penalties, and behavioral safeguards rather than voluntary ethical principles.

TRAIGA’s Behavioral Manipulation Provisions Carry High Stakes

Among the most closely watched elements of TRAIGA is its explicit prohibition on AI systems that intentionally manipulate human behavior in harmful ways. Section 552.052 of the statute bars the development or deployment of AI designed to incite or encourage physical self-harm, violence against others, or criminal activity.³

While the language is concise, its implications are substantial. The statute does not limit its application to healthcare-branded AI tools. Any conversational, predictive, or recommendation-based system that could reasonably be interpreted as encouraging harmful conduct falls within scope. This includes general-purpose large language models, chatbots, digital companions, and engagement platforms increasingly used across behavioral health, substance use treatment, and crisis response settings.

The compliance challenge is compounded by TRAIGA’s broad definition of artificial intelligence. The law defines AI systems as any machine-based system that infers from inputs to generate outputs influencing physical or virtual environments.⁴ This definition sweeps in far more than advanced generative models. Clinical decision support tools, patient engagement algorithms, and automated intake systems may all qualify, depending on how they function in practice.

For behavioral healthcare executives, the risk is not theoretical. Civil penalties range from $10,000 to $12,000 per curable violation and escalate to between $80,000 and $200,000 per uncurable violation.⁵ Enforcement authority rests with the Texas attorney general, creating a centralized and politically empowered oversight mechanism. Atlantic Health Strategies advises organizations to assume active enforcement rather than passive guidance.

Implications for AI-Enabled Mental Health and Digital Care Models

Although TRAIGA is not framed as a mental health law, its behavioral manipulation provisions intersect directly with AI-driven mental health applications. The rapid adoption of conversational AI for emotional support, cognitive coaching, and symptom navigation has outpaced regulatory clarity. Texas’s statute is one of the first broad AI laws to explicitly address the risk of AI systems influencing self-harm or violence.

This creates immediate operational questions. What constitutes intentional encouragement when an AI system responds dynamically to user inputs. How should organizations document safeguards, prompt controls, and escalation pathways. At what point does personalization become persuasion. These questions matter because TRAIGA’s language focuses on intent and foreseeable risk, not clinical labeling.

Atlantic Health Strategies has observed that many provider organizations rely heavily on vendor assurances regarding AI safety. Under TRAIGA, that posture is insufficient. Liability exposure can extend to entities that deploy AI systems, not only those that develop them.² Behavioral health providers, managed service organizations, and digital platform operators must conduct independent risk assessments and governance reviews.

Notably, TRAIGA does not create a private right of action. Enforcement runs through the attorney general. This structure increases the likelihood of high-profile cases intended to set precedent. For organizations operating at scale in Texas, reputational risk may rival financial penalties. A single enforcement action tied to AI-induced harm could ripple across payer relationships, accreditation status, and investor confidence.

A Broader Compliance Signal Beyond Behavioral Health

TRAIGA’s reach extends well beyond mental health use cases, and that breadth is intentional. The statute also addresses biometric data use by government entities, transparency obligations, and constitutional rights protections.⁶ Its stated purpose is to advance responsible AI development while protecting individuals from reasonably foreseeable risks.⁷

From a governance perspective, Texas has adopted a model that blends civil rights logic with consumer protection enforcement. This mirrors emerging regulatory strategies seen internationally and foreshadows potential federal approaches. For multi-state healthcare operators, TRAIGA underscores the necessity of jurisdiction-specific AI compliance frameworks rather than one-size-fits-all policies.

Atlantic Health Strategies emphasizes that AI governance can no longer be treated as an IT or innovation function alone. Compliance officers, clinical leadership, and risk management teams must be integrated into AI procurement and deployment decisions. Documentation of safeguards, testing protocols, and exception handling will be essential if regulators scrutinize intent and design choices.

The law also includes safe harbors and affirmative defenses related to testing and research contexts.⁸ However, these provisions are narrow and untested. Organizations should not assume experimental status will shield them from scrutiny, particularly when AI systems are accessible to the public or patients.

What Comes Next for Providers, Vendors, and Policymakers

TRAIGA takes effect at a time when federal AI legislation remains stalled. Congress has explored multiple frameworks addressing AI risk, transparency, and healthcare use, but none have advanced to enactment. In this vacuum, states like Texas are shaping the compliance landscape.

For behavioral healthcare leaders, the strategic response should be proactive. Atlantic Health Strategies recommends immediate inventorying of all AI-enabled tools, including those embedded within EHRs, patient portals, marketing platforms, and third-party applications. Each system should be evaluated for behavioral influence risk, escalation protocols, and alignment with TRAIGA’s prohibitions.

Vendors serving Texas-based providers will face increased scrutiny. Contractual representations regarding AI safety, audit rights, and indemnification are likely to become standard. Organizations that cannot demonstrate robust AI governance may find themselves excluded from enterprise procurement decisions.

From a policy standpoint, TRAIGA is unlikely to be the final word. Court challenges, enforcement actions, and subsequent amendments will shape its practical impact. Still, the law establishes a clear principle. AI systems that manipulate human behavior in harmful ways are no longer an abstract ethical concern. In Texas, they are a regulated legal risk.

Atlantic Health Strategies will continue to monitor TRAIGA’s enforcement and advise healthcare organizations on scalable, defensible AI governance models. The message from Texas is unambiguous. AI innovation must now coexist with enforceable behavioral safeguards, and the cost of ignoring that reality is rising.

References

Texas Responsible Artificial Intelligence Governance Act, Texas House Bill 149, 89th Legislature. https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00149F.htm

Texas House Bill 149, Section 551.002, Applicability. https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00149F.htm

Texas House Bill 149, Section 552.052, Restrictions on Manipulation of Human Behavior. https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00149F.htm

Texas House Bill 149, Section 551.001, Definitions. https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00149F.htm

Texas House Bill 149, Civil Penalties and Enforcement Provisions. https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00149F.htm

Texas House Bill 149, Provisions on Biometric Data and Government Use of AI. https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00149F.htm

Texas House Bill 149, Section 551.003, Purpose. https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00149F.htm

Texas House Bill 149, Safe Harbors and Affirmative Defenses. https://capitol.texas.gov/tlodocs/89R/billtext/html/HB00149F.htm

Request a Free Consultation

Scroll to Top